| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 694.37 KB | Adobe PDF | |||
| 1.74 KB | Text |
Authors
Advisor(s)
Abstract(s)
Etanercept, Infliximab and Adalimumab are the best treatment options for improving the life quality of patientssufering from rheumatoid arthtitis.
Description
Keywords
Pedagogical Context
Citation
Clemente, D., & Santos, M. (2013). The influence of TNFA genetic polymorphisms in the response to immunomodulatory drugs in patients with rheumatoid arthritis: A systematic review [Comunicação]. Second ESTSP Conference «Pharmacogenomics: from Cell to Clinic, Lisboa.